Trastuzumab

• Description:

  Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  146 kDa

• Molecular Formula:

  ——

• Notes:

  Research use only, not for human use.

• Receptor:

  HER2

• CAS Number:

  180288-69-1